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Abstract 
Aim  This paper reports a study conducted in 2004 on the determinants of attitudes 
towards hormone replacement therapy in the aftermath of the report on the findings of 
the Women’s Health Initiative study. 
Background The unexpected findings of the Women’s Health Initiative study, 
published in July 2002, showed that the risk of using combined hormones exceeded 
their benefits. This complicated women’s decision-making about hormone use and 
made it important to study the determinants of their attitudes to hormone therapy, as 
these are likely to influence their behaviour. 
Methods A cross-sectional design was conducted with a sample of 561 women drawn 
from the National Registry of Iceland. A self-administered questionnaire, measuring 
attitudes towards hormone replacement therapy, attitudes towards menopause, extent 
and source of menopausal education, symptom experience, health and lifestyle and 
knowledge about the findings of the Women’s Health Initiative, was used. The overall 
response rate was 56%. Attitudes to hormone replacement therapy were compared 
using ANOVA, t-tests and correlations. 
Results Participants generally had positive attitudes. Knowledge about the Women’s 
Health Initiative study was not associated with more negative attitudes. However, 
receiving the information from and discussing it with a doctor were associated with 
more positive attitudes. Positive attitudes towards hormone therapy were also 
associated with higher age, time since last menstrual period and current use of 
hormone replacement therapy. Negative attitudes towards were associated with use of 
natural remedies and receiving information or discussing it with family or friends.   
Conclusion Research is needed to identify the dynamics of the medical interview, 
and the nature of input from friends, spouse and other family members. The content 
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of these messages may be different and conflicting, for example between doctors and 
family members. The nature of this conflict and conflicts of interests need to be 
identified in order to inform the decision-making process of women. In addition, 
action needs to be taken in order to strengthen the advisory role of nurses.  
 
Key word :  nursing; hormone replacement therapy; menopause; attitudes; decision-
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What is already known about this topic 
 
 There was an increase in the use of combined hormone replacement therapy 
during menopause in many western countries during the 1990s. 
 In 2002 the first double blind clinical trial on use of combined hormone 
replacement therapy among healthy women (Women’s Health Initiative study) 
during menopause was discontinued due to unfavourable risk associated with 
its use. 
 Prior to the release of the study findings, a strong association had been found 
between use of hormones and women’s positive attitude towards its use. 
 
What this study adds 
 
 Icelandic women aged 47 to 53 have rather positive attitudes towards the use 
of hormone replacement therapy with hormone users having a more positive 
view than non-users. 
 Physicians exert a strong influence on women’s decision-making about use of 
hormone replacement therapy around menopause.  
 The further women are into menopause, the more favourable their attitudes. 
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INTRODUCTION 
 
 
The findings of the Women’s Health Initiative (WHI) study, made public in July 
2002, showed that the risk of using hormone replacement therapy (HRT), consisting 
of combined hormones of oestrogen and progesterone during menopause, exceeded its 
benefits (Writing Group for the Women’s Health Initiative 2002). The risk was 
considered so important as to prompt discontinuation of the study 3 years earlier than 
the initial plan. These findings provoked strong reactions. The medical perspective 
was described by Cyr (2003) as shaking “the medical community’s fundamental 
beliefs about hormone therapy” (p. 15), while the feminist and activist Worcester 
(2004) claimed that “no one should have been surprised by the news that HRT did not 
prevent heart disease and that its long-term safety was questioned. Many researchers 
and activists have been saying this for over a decade” (p. 57).  
 
Prior to this, an increase in the use of HRT had been noted in many western countries. 
In Germany, 3% of 45 to 65 year old women used HRT in 1984/85, while 23% were 
HRT users in 1994/95 (Mueller et al. 2002). In Norway, the proportion of HRT users 
aged 45 to 69 years was 16.3% in 1994 and 19.1% in 1998 (Sogaard et al. 2000). 
Similar trends were observed in Iceland, where a 5.7 fold increase in use of HRT was 
observed from 1986 to 1995 (Elíasson et al. 1998), and 57% of 52 to 57 year old 
women used HRT during the years 1996 – 2001. Long-term use also increased 
steadily in Iceland, with 67% of HRT users having been users for more than 5 years in 
1999-2001, compared with 49% in 1996-1998 (Ármannsdóttir et al. 2004).  
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During the 1990s the discourse in the health literature on menopause and hormone 
therapy shifted away from symptoms and treatment towards prevention and risk 
(Murtagh & Hepworth 2003).  
 
The dominant HRT discourse began to focus on the risk/benefit ratio of using 
hormones. Protection against coronary heart disease, osteoporosis, and during the later 
years, also Alzheimer's disease had been identified as major benefits. The risk was 
considered minimal and mostly related to a small increase in the prevalence of breast 
cancer (Grady et al. 1992, Jóhannesson et al. 1995, Grodstein et al. 1996, Col et al. 
1999, Reynolds et al. 2002). Until June 2002, the majority of recommendations to 
women on the use of HRT were therefore that, although the risk:benefit ratio was not 
known, the prevailing evidence was in favour of its use (Elíasson et al. 1998, Laborde 
& Foley 2002, Brood-van Zanten et al. 2002, Neves-e-Castro 2002). Belief in the 
benefits of HRT was based on a number of observational epidemiological studies that 
had shown, for example, that the use of combined hormones during menopause was 
associated with decreased risk of coronary heart disease averaging 30 – 50% 
(Stampfer & Colditz 1991).  
 
The WHI study was the largest-ever randomized, double-blind, placebo, controlled 
trial of HRT use among healthy women, and the major findings were in opposition to 
those of earlier observational studies. The major findings were that healthy women 
using combined hormones, compared with women using placebo, experienced 
statistically significantly more serious diseases during the five-year trial period, 
including an excess of blood clots, cardiovascular disease, breast cancer and stroke 
(Writing Group for the Women’s Health Initiative 2002). At present not many studies 
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have looked at the influence of the WHI findings on the use of HRT. However, there 
are indications that they have led to a substantial decrease in its use (Haas et al. 2004).  
 
In light of the clinical uncertainty and polemic surrounding the use of HRT, it is 
important to identify the factors that shape women’s attitudes and decisions regarding 
HRT use. Studies conducted prior to the WHI study have found various factors to 
influence the use of HRT (for a review see Krishna 2002). A strong association has 
been found between its use and a positive attitude towards the use of HRT (Woods et 
al. 1998, Sogaard et al. 2000, Legare et al. 2000, Ekström et al. 2003). Other factors 
associated with increased use of HRT include a biomedical view of menopause 
(Ferguson et al. 1989, Hunter et al. 1997, Woods et al.1998, Lomranz et al. 2000), a 
negative attitude towards menopause (Burusanont & Hadsall 2004), frequent visits to 
a physician and physicians’ recommendations to use HRT (MacDougall et al. 1999, 
Sogaard et al. 2000, Merom et al. 2002, Hvas et al. 2003, Lewin et al. 2003, Ekström 
et al. 2003, Fistonic et al. 2004), access to more information about HRT (Burusanont 
& Hadsall, 2004) and increased symptom experience (MacDougall et al. 1999, Kittell 
& Mansfield 2000, Li et al. 2000; Merom et al. 2002; Ekström et al. 2003). Study 
findings have been contradictory as to the influence of higher education on HRT use, 
some reporting an association between higher education and use of HRT (Li et al. 
2000, Merom et al. 2002, Banks et al. 2002, Rachon et al. 2004) and others not 
(Mueller 2002; Ekström et al. 2003; Fistonic et al. 2004) or reporting ambivalence 
towards the use of HRT among educated women (Sogaard et al. 2000). Fistonic et al. 
(2004) showed no association between marital status, employment or age and HRT 
use. However, Merom et al. (2002) found that prevalence of HRT use was highest 
among 55 to 59 year old women in a sample ranging in age from 45 years to 74 years. 
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Ekstrom et al.(2003) found that use of HRT was highest among 55 to 60 year olds, 
compared with 45 to 50 year olds. Rachon et al. (2004) found that the prevalence was 
higher among 45 to 54 year old women, than those who were 55 years and older.  
 
A search on the web of science on hormone replacement therapy, attitudes and 
decision-making found two studies on these issues conducted after July 2002.  Blümel 
et al. (2004) study focused on the degree of knowledge and on the reactions to the 
WHI study among 600 women and 283 physicians residing in Santiago, Chile. The 
main findings were that 35% of HRT users contacted physicians after they heard 
about the WHI study and 4% abandoned it use. Changes in physicians’ attitudes were 
reflected by their prescribing practices, with 64.7% modifying their clinical approach, 
e.g. applying more rigorous risk/benefit assessment, lowering the dose of HRT and 
shortening the duration of HRT. Prescription of HRT dropped 8.6% in the 3 months 
following the publication of the WHI study. However, only 2.3% of the physicians 
stated that a part of the change in their clinical approach involved educating patients. 
A study by Moen et al. (2005) on Norwegian gynaecologists’ attitudes toward HRT 
after the results of the WHI were known as compared to earlier studies on their 
attitudes found significant attitudinal changes. The major finding was that in the 
autumn of 2002 16.4% of respondents said that all women should be offered HRT 
compared to 38.2% in 1997 and 33.5% in the spring of 2002. There was a significant 
difference in the gynaecologists’ response to increased risk of breast cancer, 
protection against thrombosis and protection for ischemic heart disease in the 
direction of the findings of the WHI study. Interestingly, the personal hormone use of 
female gynaecologists or the partners of male gynaecologists did not change at all 
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from spring to autumn 2002, indicating that none of them stopped the treatment due to 
the results of the WHI study. 
 
The Icelandic Ethical Standards for Nurses states in article 7 that “The nurse shall 
concern himself/herself with the development of knowledge 
regarding nursing and build his/her job upon research results for the 
benefit of the patient” (The Icelandic Nurses’ Association, 1999). Similar thought is 
found in the ICN Code of Ethics for Nurses (The International Council of Nurses, 
2000). At present, it seems that knowledge on how women decide on the use  of HRT 
in the aftermath of the WHI is limited. No published studies on HRT where found in 
nursing journals that were conducted after the findings of the WHI were made public. 
Actually there is not much published on HRT in nursing journals. However, due to the 
fact that HRT affects large number of women and is one of the best-selling drug 
regimes of all time it seems imperative, that nurses be knowledgeable about the 
controversies of HRT in order for them to meet the ethical standard of their profession 
and base their practice on best research evidence available. The aim of this study is to 
explore the attitudes towards HRT and identify factors associated with a negative or a 
positive attitude to HRT. In Iceland, no studies have been conducted on attitudes 
towards HRT use or other important correlates of its use. Iceland represents an 
interesting case for a study of determinants of HRT use due to its cultural 
homogeneity, including general access to a socialised health care system 
(Vilhjálmsson, 2005) and a widespread but limited number of media sources.  
 
THE STUDY 
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Aim 
 
The aims of the study were to illuminate how women make decisions about HRT by 
describing their attitudes towards it, and to determine the effect of demographic 
characteristics, attitudes towards menopause, extent and source of menopausal 
education, symptom experience, health and lifestyle and knowledge about the findings 
of the WHI study on these attitudes. 
 
Design 
 
A cross-sectional design was used, with a postal questionnaire and one follow-up 
reminder. The data were collected in 2004 
 
Participants  
 
A random sample of 1000 women born 1951 through 1957, residing in the capital of 
Iceland, Reykjavík, and neighbouring towns was drawn from the National Registry of 
Iceland. This represented 12.6% of the population. The response rate was 56% 
(N=561), ranging from 52% to 61% in individual year groups. The composition of the 
sample also reflected adequately the marital status of the population.  
 
Questionnaire 
 
The questionnaire was mostly designed by the first author, assisted by three nursing 
students. The questions addressed socio-demographics, perceived menopausal status, 
information about menopause, sources of information about menopause, perceived 
information adequacy, present or previous use of HRT and intention to use HRT, 
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symptom experience, attitudes towards menopause, attitudes towards HRT, 
knowledge about the 2002 findings of the WHI study, use of other methods to 
alleviate menopausal symptoms, and health and lifestyle. 
 
Menopausal status was assessed by asking “Are you menopausal?”( yes/no/don’t 
know). Information about menopause was assessed with two questions: “Have you 
received enough information about menopause?” (yes/no) and “Do you think that the 
health authorities should provide more information about menopause?” (yes/no). 
Sources of information were identified by asking “Where did you receive information 
about menopause?”. Participants responded by checking (or not) 10 possible sources 
(see Table 3). Use of HRT and intention to use HRT was assessed by four questions: 
“Have you ever used HRT?”; “Are you presently using HRT?”; “Have you considered 
to stop using HRT?” and “Have you considered using HRT?”. Possible answers were 
yes and no. Participants were asked for the presence (yes/no) of any of 18 symptoms 
in relation to peri-menopause, including hot flushes, sleep disorders, fatigue and 
anxiety (see Table 6).  
 
Attitudes towards menopause (ATM) were assessed with six statements that were 
developed by Hvas et al (2003) (see Table 1). The statements were tested for internal 
consistency and when two statements had been removed the Cronbach’s alpha was 
0.72. The statements that were removed were “Menopause is a normal part of 
women’s life” and  “Menopause is a period one has to tackle”.  Attitudes towards 
HRT were assessed with 7 items also developed by Hvas et al (2003) (see Table 1). 
Cronbach’s alpha for this scale was 0.84. Possible answer to each statement were 
agree, disagree and neutral. The statements on attitude towards menopause and on 
Attitudes of Icelandic women to use of HT 
 
12 
12 
attitude towards HRT were translated into Icelandic by nursing students and back 
translated by two specialists with good knowledge of English and Icelandic 
(Sigurdardóttir et al. 2004).  
 
A number of questions addressed knowledge about the WHI study. Prior to these 
questions the participants were introduced to the WHI study with this text: “In the 
summer of 2002, the first results of a US study on the use of HRT were published. 
The results have generated a considerable debate in this country and abroad.” 
Participants were then asked “Have you heard about the above mentioned study?” 
(yes/no).  If yes, they were asked “Where did you hear about the study?” Participants 
responded by checking (or not) 10 possible sources (see Table 3). Then they were 
asked, “With whom have you discussed the outcome of the study?” and participants 
checked (or not) 9 possible agents (see Table 5). 
 
Participants were asked, “Have you used any of the following remedies for 
menopausal symptoms?” (see Table 7). Eight questions related to health and life style. 
Participants were asked to rate their general health, physical well-being and 
psychological well-being (very good/good/reasonable/bad). These three were 
combined into one scale labelled Self assessed health (Cronbach’s alpha = 0.85). In 
two questions, participants were asked to compare their health and physical activity 
with the health and physical activity of other women their own age. Possible 
responses were worse, similar and better. These two questions were combined into 
one scale labelled Relative health and physical activity (Cronbach’s alpha = 0.71). 
Participants were asked, “Do you engage in physical exercise regularly?” (daily or 
almost daily/3-5 times a week/1-2 times a week/less than once a week/less than once a 
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month or never); “Do you smoke or have you ever smoked?” (no, have never 
smoked/no, smoked but quit smoking more than a year ago/no smoked but quit 
smoking less than a year ago/yes, but smoke more seldom than daily/yes, smoke 
daily); “Do you eat at least three meals a day?” (no, almost never/yes, a few times a 
month/yes, one or two days a week/yes, three or four days a week/yes, five to seven 
days a week). 
 
The questionnaire was piloted for clarity by administering it to 10 women aged 47 to 
53. Minor changes were made on the final version based on participants’ suggestions. 
 
Ethical considerations 
The National Bioethics Committee approved the study and the Data Protection 
Commission was informed, according to Icelandic law. Along with the questionnaires 
an introductory letter was mailed to all potential participants were they were informed 
that participation was voluntary and that the data would be reported in an anonymous 
and confidential manner.  
Data analysis  
The main variable of the study was the measure of attitudes to HRT. It consisted of 
the mean of agreement/disagreement ratings of seven statements about HRT. 
Statements expressing negative attitudes to HRT were reverse-scored. For further 
analysis, the responses for each statement were scored (1=disagree, 2=neutral and 
3=agree) and averaged, and the total average score found for the attitude scale. A high 
score thus indicated positive attitudes. Cronbach’s alpha for the scale was 0.84.  
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Attitudes to HRT were compared using ANOVA, t-tests and correlations (Spearman 
and Pearson) as appropriate. Variables showing statistically significant differences 
from or statistically significant relationships with the attitude scale were entered into a 
multiple regression model. The variables were entered in separate blocks and 
precedence given to those that, arguably, are earlier in the causal chain. Within each 
block, the enter method was employed, i.e. all variables in a block are entered in a 
single step.Within each block, the enter method was employed. 
 
RESULTS 
 
Attitudes to HRT and menopause 
Seven statements measured attitudes towards HRT and another six items measured 
attitudes to menopause. Scales were developed for each of these. However, it is of 
interest to show the proportion of participants who agree, disagree or are neutral 
towards each statement. This is shown in Table 1.  
INSERT TABLE 1 HERE 
The Pearson correlation between attitudes to menopause and attitudes to HRT was r= 
-.034 (p=0.228).  
Background variables 
The correlation of attitudes to HRT with age and number of children was r=0.128; 
(p=0.006) and r=0.04; (p=0.361) respectively, indicating a small positive association 
between age and attitudes to HRT.  
 
Three ANOVA’s were conducted to explore the relationship between attitudes to 
HRT and marital status, education and occupation respectively. Means, standard 
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deviations and the outcome of the ANOVAs are shown in Table 2.None of the 
relationships were statistically significant.  
 
INSERT TABLE 2 HERE 
 
Menopausal status 
The relationship between attitudes to HRT and various indicators of menopausal 
status was tested. A series of ANOVAs and t-tests failed to show any effect of 
perceived regularity of period, menopausal status (whether menopause is reached or 
not) or the use of contraceptives on attitudes to HRT. However, a medical intervention 
such as unilateral oophorectomy is associated with more negative attitudes towards 
hormone therapy, bilateral oophorectomy is associated with more positive attitudes. 
No significant differences in attitudes are associated with hysterectomy. 
 
There was a very weak correlation between attitudes to HRT and length of time since 
last period (r=0.10; p=0.018) such that more positive attitudes are associated with 
longer time elapsed since last period.  
Information 
Two sets of questions addressed the issue of participants’ sources of information 
about menopause and about the WHI study. The effect of the received information on 
attitudes to HRT was assessed (see Table 3). Results indicate that receiving 
information from a doctor is associated with more positive attitude to hormone 
therapy. Conversely, receiving information from spouse and other friends than female 
friends is associated with more negative attitudes to hormone therapy. Similarly, 
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receiving information from doctors about the WHI-study is associated with more 
positive attitudes to hormone therapy.  
INSERT TABLE 3 HERE 
Attitudes to HRT were also compared on a number of other questions relating to 
information about menopause and the WHI-study (see tables 4 and 5).  
INSERT TABLE 4 HERE 
INSERT TABLE 5 HERE 
Overall, there are no differences in attitudes to HRT linked to whether participants 
have heard of the WHI-study or not, felt they had received enough information about 
menopause or whether they believed health authorities should do more to promote 
information about menopause. However, discussing the outcome of the study with the 
doctor is associated with more positive attitudes towards HRT but discussing it with 
children is associated with a more negative attitude.  
Symptoms 
No differences were observed in the attitudes of those who had experienced 
symptoms vs. those who had not (see table 6). However, the Spearman correlation 
between total number of symptoms and attitudes to HRT was significant (rho=0.09; 
p=0.035).  
INSERT TABLE 6 HERE 
Use of alternative remedies  
The attitudes to HRT therapy were examined as function of the use of various 
alternative remedies (table 7). 
INSERT TABLE 7 HERE 
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Three of the alternative remedies show a difference in attitudes towards HRT with 
users showing more negative attitudes towards HRT than non-users. A similar 
tendency is observed for all the other remedies except chiropractic, albeit not 
significantly. A user-index of alternative medicines was computed, representing the 
total number of different alternative remedies used. This scale had a correlation of 
rho= -0.10 (p=0.022), indicating that use of alternative remedies is negatively related 
to attitudes towards HRT therapy.  
Other health indicators 
The association between various health indicators and attitude to HRT was assessed. 
Spearman’s rho was computed between attitudes towards HRT and perceived health 
(rho=0.028; p=0.277) and with perceived relative health (rho=-0.04; p=0.383). In 
addition, attitudes were correlated with three single items measures: The practice of 
physical exercise (rho= 0.035; p=0.427), the frequency of eating at least three meals 
per day (rho= -0.059;p=0.182) and smoking (rho= -0.003; p=0.942). The number of 
times participants went to the doctor during the last year was positively associated 
with attitudes towards HRT (rho=0.125; p=0.004).  
User status 
Attitudes towards HRT were examined depending on participants’ hormone user 
status (see Table 8). ANOVA was significant (F(4.539)=27,927; p<0.001). As 
expected, the attitudes are more favourable among users and previous users than 
amongst non-users. 
INSERT TABLE 8 HERE 
 
Regression analysis 
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Based on the above computations, a multiple regression model to explain attitudes 
towards HRT was tested. Variables were entered if the analyses above had shown 
significant links with attitudes towards HRT. Variables were entered in four blocks 
arguably reflecting a causal order (see Table 9). This produces four successive models 
consisting of one to four blocks respectively. The enter method was used within 
blocks.  
INSERT TABLE 9 HERE 
The explained variance in each block is 1.9%, 8.1%, 2.8% and 10.8% respectively, 
leading to a total R2 of 0.237 (adjusted R2 of 0.201). While the contribution of each 
variable is not always significant the results suggest that attitudes to HRT are more 
favourable as participants enter further into menopause. Receiving information from 
doctors is associated with more positive attitudes, but information from friends and 
family is associated with more negative views. Not surprisingly, the use of natural 
alternative drugs is associated with negative views towards HRT. The first three 
blocks explain a total of 12.8% of the variance. In addition, users who have not 
considered stopping and users who have considered stopping hormone use have more 
positive attitude than the comparison groups of non-users. The final model explains 
23.7% of the variance.  
 
DISCUSSION 
 
This first national study of women’s attitudes towards the use of HRT found that 
Icelandic women aged 47 to 53 have a rather positive attitude towards its use, with 
HRT users having a more positive view than non-users. This is in accordance with 
previous studies that have found positive attitude to be associated with the use of or 
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the intention to adopt HRT (Woods et al. 1998; Sogaard et al. 2000; Legare et al. 
2000; Ekström et al. 2003).  
 
The study indicates that receiving information about menopause and about the WHI-
study from doctors is associated with more positive attitudes towards HRT. Similar 
findings have been reported in several other studies (MacDougall et al. 1999, Sogaard 
et al. 2000, Merom et al. 2002, Ekström et al. 2003, Lewin et al. 2003, Fistonic et al. 
2004, Hvas et al. 2003). A debate on the possible reasons for this is present in the 
literature. Some maintain that doctors adhere too rigidly to the medical model that has 
presented the menopause as a deficiency disease and that most women would benefit 
from HRT use. Moreover, studies with female physicians have found that they were 
more likely to use HRT than other women (Isaacs et al. 1995, Andersson et al. 1996, 
McNagny et al. 1997) and that they have not stopped using HRT following the 
findings of the WHI (Moen et al. 2005), lending further support to the view that 
physicians trusted in the benefits of using HRT and therefore recommended its use to 
women. Others point out that the women who visit doctors tend to be those with the 
most severe symptoms and are therefore in greatest need for HRT. 
 
Since women who have sought information from doctors about menopause and HRT 
have more positive attitudes towards HRT than those who have not, it is imperative to 
research doctors recommendations on the issue. What is the content of the message 
they are giving to women, in light of the results of the WHI study? An observational 
study on how the subject of HRT is brought up and how the discussion unfolds during 
a woman’s visit to a physician is highly relevant. An interesting question to ask is 
how the risk/benefit analysis of HRT use would be presented and discussed during the 
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women/physician interaction. An example of that kind of research is Fisher’s (1988) 
study on medical decision making regarding treatment following a detection of 
cervical dysplasia. The study indicated that the mechanisms by which the physician 
structures the medical interview predetermine women’s questions and the general 
outcome of the interview, including treatment decision.   
 
A small number of participants received information from nurses about menopause 
and the WHI and discussed the outcome of the WHI with a nurse. In Iceland nurses 
mostly meet healthy women at Community Health Centers since there are no specific 
Women’s Health Centres in Iceland  The common practice is that if women have 
complaints or have questions about health matters specific to women they make an 
appointment with a gynaecologist at his or her private office. It is not customary for a 
nurse or a third person to be present during the interview. Therefore this finding was 
not surprising. It is however, our belief that by strengthening the consultation role of 
nurse’s women would benefit. This belief is based on the different approaches nurses 
take in their practice as compared to physicians well described by Fisher (1995) in a 
study on communication between nurse practitioners and women-patients as 
compared to physicians and women-patients. The study indicates that nurses tend to 
distance themselves from their professional identities, respond to their patients 
woman to woman and thereby undermine the traditional understandings about gender 
arrangements. Fisher’s conclusions were that nurses are more egalitarian and less 
hierarchical than physicians are and that they deliver health care in a way that favours 
ideals of democracy, equity and fairness.  
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The study presented here found that receiving information from family and friends 
was associated with more negative attitude towards HRT, indicating that they are 
rather conservative towards the use of HRT than women. This includes spouse, 
assumed male in most instances, and other friends that, also assumed to be male. This 
is interesting since it might indicate that men are more conservative towards the use 
of HRT than women, which would comply with a trend that has been found when 
male physicians have been compared to female physicians (Seto et al. 1996, Excline 
et al. 1998). The importance of information on the attitudes to HRT is confirmed in 
the present study as variables measuring access to information contributed 8.1% to 
the total variance explained. These findings also indicate that there is not a strong 
societal pressure to use HRT.  
 
While 51% of women claim they have received information about menopause in the 
media, this is not reflected in differences in attitudes towards HRT if compared to 
those not receiving information from the media. A detailed analysis on the coverage 
of menopause and HRT in Icelandic media has not yet been conducted. However, 
studies from the UK and USA have found the portrayal of menopause and the 
management of menopause in the media to be diverse in content. A biomedical 
perspective is dominant, but less prominent are views that build on holistic approach 
and a combination of social, cultural, psychological and physiological factors. 
However, information is contradictory and limiting and menopause is mostly 
negatively portrayed (Gannon & Stevens 1998, Lyons & Griffin 2003). Studies on 
media coverage have not included Internet exposure. Over 80% of the Icelandic 
population, aged 16 to 74 are Internet users (Statistical Series 2004). Thus it is 
difficult to conclude about the content of information on HRT accessible to Icelandic 
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women in the media and on the Internet. In light of our finding that receiving 
information on menopause from the media is not associated with either a more 
positive or negative attitude to HRT, it is important to examine the content of 
information on HRT accessible to Icelandic women through media sources. 
 
Higher age and time elapsed since last menstrual period was associated with a more 
positive attitude towards HRT. Direct comparison to other studies is difficult since the 
age of the participants is restricted to peri-menopause i.e. women aged 47 to 53 years. 
Phelan et al. (2001) study found positive attitudes associated with younger age among 
women aged 50 to 80 years while Wagner et al. (1995) found that middle aged 
women held more positive attitudes towards HRT than college students. The effect of 
age may be a reflection of a number of other less accessible factors, social, 
psychological and biological, which affect women differently. These factors need to 
be identified, as age is only a reflection of what happens to you in different life 
periods. 
 
The study showed a weak correlation between attitudes towards HRT and total 
number of menopausal symptoms. This is in accordance with studies that have found 
symptoms experience to influence use of HRT (MacDougall et al. 1999, Li et al. 
2000, Kittel & Mansfield 2000, Merom et al. 2002, Ekström et al., 2003).  Future 
studies should also assess the severity of symptoms and not merely their presence as 
was the case in the present study, since the severity may be a better predictor of HRT 
use.  
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As expected, the use of alternative ‘natural’ remedies is associated with more 
negative attitudes towards HRT. Among these are meditation, relaxation and the use 
of natural medicine. The trend in studies that have addressed the use of alternative 
remedies has been that never-users of HRT are more in favour of using these 
remedies (Newton et al. 2002, Lewin et al. 2003). This may reflect an overall culture 
of aversion to “drugs” (HRT being one such) leading some people to try other more 
‘natural’ remedies. 
 
CONCLUSION 
 
Further research needs to identify the content of the messages sent out to women via 
the media, the dynamics of the medical interview, and the nature of input from 
friends, spouse and other family members. The content of these messages may be 
different and conflicting, as the present study shows to be the case, e.g. between 
doctors and family. The nature of this conflict, and possible conflicts of interests, 
needs to be identified in order to inform the decision making process of women.  
In addition, action needs to be taken in order to strengthen the advisory role of 
nursing.  
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Table 1 Attitudes to menopause and hormone therapy (HRT). Percentage of participants who agree, disagree or 
are neutral to various statements about menopause and hormone replacement therapy 
Attitudes to menopause 
Agree 
(%) 
Disagree 
(%) 
Neutral 
(%) 
Mean   SD*  
Menopause is a normal part of women’s life 95 1 4 2.9      0.3    
Menopause is a good experience for women 11 34 54 1.8      0.6 
Menopause is a period of personal growth 27 20 53 2.1      0.7 
Menopause is a period one has to tackle 88 3 9 2.9      0.4 
Menopause is a boring time for women+ 37 20 43 2.2      0.7 
Menopause is a bad experience for women+ 21 23 53 2.0      0.7 
Attitudes to HRT therapy     
HRT is a good solution if one has many symptoms 71 5 24 2.7      0.6 
HRT is a good solution, even if one experiences only few 
symptoms 19 42 39 
 
1.8      0.8 
HRT is to be avoided+ 29 34 37 2.0      0.8 
HRT is unhealthy+ 14 40 46 1.7      0.7 
HRT is a good solution to prevent age-related health problems 27 22 51 2.0      0.7 
HRT is a bad solution to prevent age-related health problems+ 19 28 53 1.9      0.7 
HRT has many side-effects+ 29 13 58 2.2      0.6 
 
Note: *In calculating the mean and SD the responses were scored: Agree=3, 
Disagree=1 and Neutral=2.  
 + These items were reversed for inclusion in the total attitudes.  
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Table 2 Mean and standard deviation of attitudes towards hormone therapy by 
marital status, education, occupation and menopausal status 
Background variables N Mean SD ANOVA 
Marital status     
Single 39 2.1 0.6 F(3,536)=0.993; p=0.396 
Married/cohabiting 412 2.2 0.6  
Widow 7 2.9 0.6  
Divorced 82 2.2 0.6  
Education     
  Lower secondary  
     school 175 2.1 0.6 F(5,531)=1.042; p=0.392 
Commercial College 29 2.3 0.5  
Technical  40 2.2 0.6  
  Upper secondary  
      school 43 2.1 0.5  
University degree 174 2.1 0.6  
Other 76    
Occupation     
Clerk 125 2.2 0.6 F(6,514)=0.838; p=0.541 
Expertise 139 2.1 0.6  
Industrial expertise 26 2.2 0.6  
Office manager 118 2.2 0.5  
Company owner 73 2 0.6  
Student 3 2.5 0.8  
Housewife 37 2.2 0.6  
Menopausal status 
Have you reached menopause?   
Yes 270 2.2 0.6 F(2,524)=2.33; p=0.098 
No 108 2.1 0.6  
Don’t know 149 2.2 0.5  
Regularity of period    
Regular 166 2.1 0.6 F(2,402)=0.397;p=0.672 
Irregular 86 2.1 0.6  
No period 153 2.2 0.6  
Use of contraceptives at present   
Yes 101 2.1 0.6 t(431)= 0.650; p=0.516 
No 332 2.2 0.6  
Unilateral oophorectomy    
Yes 31 1.9 0.8 t(462)=-2.366;p=0,018 
No 433 2.2 0.6  
Bilateral oophorectomy    
Yes 23 2.5 0.6 t(464)= 3.199;p=0,001 
No 443 2.2 0.6  
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Hysterectomy     
Yes 80 2.3 0.6 t(502)= 1.813; p.=0.070 
No 424 2.2 0.6  
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Table 3 The attitudes towards hormone thearpy (Mean, SD) as function of sources of 
information about menopause and sources of information about the WHI-study. Percentage of 
participants who have received information from each source is indicated 
     
  Accessed source 
Did not access 
source  
Sources of information 
about menopause % Mean SD Mean SD T-test 
Mass media 51 2.2 0.6 2.2 0.6 t(514)=0.023; p=0.982 
Spouse 3 1.8 0.7 2.2 0.6 t(514)=1.971; p=0.049 
Friends (female) 46 2.1 0.6 2.2 0.6 t(514)=1.078; p=0.282 
Other friends 5 1.9 0.6 2.2 0.6 t(514)=2.540; p=0.011  
Colleagues  19 2.2 0.6 2.2 0.6 t(514)=-0.572; p=0.568 
Children 1 2.2 0.5 2.2 0.6 t(514)=-0.345; p=0.731 
Mother 14 2.2 0.6 2.2 0.6 t(514)=-0.935; p=0.350 
Doctor 37 2.3 0.5 2.1 0.6 t(514)=-3.828; p=0.001 
Nurse 7 2.2 0.6 2.2 0.6 t(514)=-0.342; p=0.732 
The Internet 17 2.1 0.6 2.2 0.6 t(514)=-1.845; p=0.066 
 
  Accessed source 
Did not access 
source  
Sources of information 
about the WHI-study % Mean SD Mean SD T-test 
Mass media 96 2.2 0.6 2.4 0.6 t(345)=-1.114; p=0.266 
Spouse 3 2.1 0.6 2.2 0.6 t(346)=0.372; p=0.710 
Friends (female) 17 2.3 0.6 2.2 0.6 t(346)=1.321; p=0.187 
Other friends 2 1.9 0.6 2.2 0.6 t(346)=-1.380; p=0.168 
Colleagues  17 2.3 0.5 2.2 0.6 t(346)=1.162; p=0.246 
Children 1 2.3 0.4 2.2 0.6 Too few cases 
Mother 1 2.2 0.5 2.2 0.6 Too few cases 
Doctor 16 2.4 0.5 2.1 0.6 t(346)=2.815; p=0.005 
Nurse 4 2.4 0.5 2.2 0.6 t(346)=1.796; p=0.073 
The Internet 7 2 0.6 2.2 0.6 t(346)=-1,688; p=0.092 
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Table 4 The attitudes towards hormone therapy (Mean, SD) as function of perceived adequacy of 
information about menopause and knowledge of the WHI-study 
 Yes No  
 Mean SD Mean  SD T-test 
Have you received enough information 
about menopause?  2.2 0.6 2.1 0.6 t(512)=0.497; p=0.620 
Do you think that the health authorities 
should provide more information about 
menopause? 2.2 0.6 2.1 0.6 t(516)=0.279; p=0.780 
Have you heard about the (WHI study)? 2.2 0.6 2.2 0.6 t(534)=0.220; p=0.826 
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Table 5 The attitudes towards hormone therapy (Mean, SD) as function of persons with whom 
the participants have discussed the outcome of the study. Percentage of participants who have 
received information from each source is also indicated 
Have  
discussed with 
Have not 
discussed with 
With whom have 
you discussed the 
outcome of the 
study? % Mean SD Mean  SD T-test 
No-one 15 2.2 0.6 2.2 0.6 t(346)=-0.095; p=0.924 
Spouse 25 2.2 0.6 2.2 0.6 t(346)=0.757; p=0.450 
Friends (female) 57 2.1 0.6 2.2 0.6 t(346)=-1.134; p=0.258 
Other friends 6 2 0.6 2.2 0.6 t(346)=-1.486; p=0.138 
Colleagues 35 2.2 0.6 2.1 0.6 t(346)=1.355; p=0.176 
Children 4 1.8 0.7 2.2 0.6 t(346)=-2.086; p=0.038 
Mother 5 2.1 0.6 2.2 0.6 t(346)=-0.303; p=0.762 
Doctor 37 2.3 0.6 2.1 0.6 t(346)=4.174; p=0.001 
Nurse 4 2.3 0.6 2.2 0.6 t(346)=0.802; p=0.423 
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Table 6 Mean and standard deviation of attitudes towards hormone therapy by experience (or not) 
of symptoms associated with menopause 
 
Experienced 
symptoms 
Did not 
experience 
symptoms  
Symptoms % Mean SD Mean SD T-test 
No symptoms 20 2.1 0.6 2.2 0.6 t(529)=-1.799; p=0.073 
Hot flashes 58 2.2 0.6 2.2 0.5 t(529)=0.123; p=0.902 
Sleep disturbance 51 2.2 0.6 2.1 0.6 t(529)=1.668; p=0.096 
Mood swings 34 2.2 0.6 2.1 0.6 t(529)=0.992; p=0.322 
Anxiety attacks 26 2.2 0.6 2.1 0.6 t(529)=1.501; p=0.134 
Oversensitivity 31 2.2 0.6 2.2 0.6 t(529)=0.114; p=0.910 
Crying spells 13 2.2 0.6 2.2 0.6 t(529)=0.777; p=0.437 
Difficulty   
concentrating 17 2.2 0.6 2.2 0.6 t(529)=0.142; p=0.887 
Restlessness 27 2.2 0.6 2.1 0.6 t(529)=1.645; p=0.101 
Changes in heart-beat 24 2.2 0.6 2.2 0.6 t(529)=0.182; p=0.856 
Feeling exhausted 35 2.2 0.6 2.1 0.6 t(529)=1.814; p=0.070 
Woke up tired 33 2.2 0.6 2.1 0.6 t(529)=0.409; p=0.639 
Other sleep problems 7 2.2 0.7 2.2 0.6 t(529)=0.631; p=0.528 
Muscle & joint-aches 33 2.2 0.6 2.1 0.6 t(529)=0.782; p=0.435 
Vaginal irritation 17 2.1 0.6 2.1 0.6 t(529)=-0.413; p=0.680 
Increased sex drive 6 2.1 0.7 2.2 0.6 t(529)=-0.991; p=0.322 
Decreased sex drive 27 2.2 0.6 2.1 0.6 t(529)=1.261; p=0.208 
Respiratory difficulties 5     2.0 0.6 2.2 0.6 t(529)=-1.867; p=0.062 
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Table 7 The attitudes towards hormone therapy (Mean, SD) as function of use (or not) of 
various alternative remedies. Percentage of participants who have used each remedy 
  Used remedy 
Did not use 
remedy  
Alternative remedy % Mean SD Mean SD T-test 
Natural hormone 15% 2.1 0.6 2.2 0.6 t(496)=-0.770; p=0.422 
Vitamins/Minerals 40% 2.1 0.6 2.2 0.6 t(495)=-1.485; p=0.138 
Herbal tea 12% 2.1 0.6 2.2 0.6 t(495)=-0.693; p=0.489 
Relaxation  17% 2.0 0.6 2.2 0.6 t(494)=-2.346; p=0.019 
Homeopathic 2% 2.0 0.6 2.2 0.6 t(494)=-1.075; p=0.283 
Acupuncture 3% 2.0 0.6 2.2 0.6 t(439)=-0.774; p=0.439 
Natural medicine  12% 2.0 0.6 2.2 0.6 t(439)=-2.466; p=0.014 
Chiropractic  2% 2.3 0.3 2.2 0.6 t(495)=0.066; p=0.947 
Meditation 6% 1.9 0.5 2.2 0.6 t(495)=-1.973; p=0.049 
None of the above 46% 2.2 0.6 2.1 0.6 t(495)=2.220; p=0.027 
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Table 8 Attitudes to hormone use by user status 
Status N Mean SD 
Has never used and has not considered starting use 252 2.0 0.6 
Has never used, but has considered starting use 55 2.2 0.5 
Uses now and has not considered stopping use 56 2.6 0.3 
Uses now, but has considered stopping use 68 2.5 0.5 
Used previously, but has stopped use 113 2.1 0.6 
Total 554 2.2 0.6 
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Table 9 Final regression model explaining attitudes towards hormone therapy 
 B Std.error Beta t 
 
 
Sig. 
Confidence 
interval 
Lower  
bound 
Model 1       
Constant 1.979 .080  24.677 .000 1.821 
Age .026 .017 .091 1.550 .122 -.007 
Time since last period .016 .015 .067 1.126 .261 -.012 
Number of menopausal symptoms .005 .009 .033 .595 .552 -.013 
Model 2       
Constant 1.954 .079  24.590 .000 1.797 
Age .018 .017 .061 1.066 .287 -.015 
Time since last period .015 .014 .061 1.061 .289 -.013 
Number of menopausal symptoms -.001 .009 -.005 -.094 .925 -.019 
Received information about menopause from 
spouse 
-.286 .197 -.077 -1.451 .148 -.673 
Received information about menopause from 
other friends 
-.256 .146 -.094 -1.753 .081 -.543 
Received information about menopause from 
doctor 
.100 .070 .081 1.424 .155 -.038 
Received information about WHI-study from 
doctor 
.072 .095 .045 .757 .450 -.115 
Discussed outcome of WHI-study with my 
children 
-.368 .173 -.116 -2.129 .034 -.708 
Discussed outcome of WHI-study with doctor 
 
.209 .076 .169 2.741 .006 .059 
Model 3       
Constant 1.870 .105  17.865 .000 1.664 
Age .018 .017 .061 1.060 .290 -.015 
Time since last period .011 .014 .046 .798 .426 -.017 
Number of menopausal symptoms .004 .010 .023 .406 .685 -.015 
Received information about menopause from 
spouse 
-.300 .195 -.081 -1.543 .124 -.683 
Received information about menopause from 
other friends 
-.210 .145 -.077 -1.445 .150 -.495 
Received information about menopause from 
doctor 
.110 .070 .090 1.580 .115 -.027 
Received information about WHI-study from 
doctor 
.042 .095 .026 .439 .661 -.145 
Discussed outcome of WHI-study with my 
children 
-.281 .174 -.089 -1.612 .108 -.624 
Discussed outcome of WHI-study with doctor 
 
.203 .076 .165 2.675 .008 .054 
Use of alternative natural remedies -.068 .025 -.159 -2.755 .006 -.116 
How often did you go to the doctors last year? .066 .035 .104 1.864 .063 -.004 
Attitudes of Icelandic women to use of HT 
 
42 
42 
Model 4       
Constant 1.925 .101  19.044 .000 1.726 
Age .005 .016 .017 .307 .759 -.026 
Time since last period .003 .014 .011 .199 .842 -.024 
Number of menopausal symptoms -.011 .009 -.069 -1.217 .225 -.030 
Received information about menopause from 
spouse 
-.305 .183 -.082 -1.666 .097 -.666 
Received information about menopause from 
other friends 
-.177 .137 -.065 -1.296 .196 -.447 
Received information about menopause from 
doctor 
.064 .067 .052 .960 .338 -.067 
Received information about WHI-study from 
doctor 
-.024 .090 -.015 -.267 .789 -.201 
Discussed outcome of WHI-study with my 
children 
-.321 .164 -.101 -1.952 .052 -.645 
Discussed outcome of WHI-study with doctor .134 .074 .109 1.812 .071 -.012 
Use of alternative natural remedies -.052 .023 -.121 -2.206 .028 -.097 
How often did you go to the doctors last year .037 .034 .059 1.100 .272 -.029 
Uses now but has considered stopping use .498 .109 .279 4.591 .000 .285 
Uses now and has not considered stopping use .638 .110 .327 5.817 .000 .422 
Used previously, but has stopped use .154 .087 .105 1.773 .077 -.017 
Has never used, but has considered starting 
use 
.291 .104 .148 2.809 .005 .087 
       
 
 
